scholarly article | Q13442814 |
P50 | author | Wiktoria Maria Suchorska | Q57614180 |
P2093 | author name string | Ewelina Augustyniak | |
Magdalena Łukjanow | |||
P2860 | cites work | The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway | Q22065419 |
How ageing processes influence cancer | Q22251048 | ||
An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells | Q24293077 | ||
Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation | Q24563808 | ||
The DNA-damage response in human biology and disease | Q24606586 | ||
DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells | Q24644828 | ||
DNA damage repair pathways in cancer stem cells | Q26859012 | ||
DNA repair in human pluripotent stem cells is distinct from that in non-pluripotent human cells | Q27309692 | ||
Death and anti-death: tumour resistance to apoptosis | Q28217065 | ||
DNA mismatch repair | Q28256190 | ||
Ionizing radiation injuries and illnesses | Q28302724 | ||
Apoptosis: a review of programmed cell death | Q28305845 | ||
Repair at single targeted DNA double-strand breaks in pluripotent and differentiated human cells | Q28478289 | ||
Identification of cisplatin-regulated metabolic pathways in pluripotent stem cells | Q28534469 | ||
RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial | Q29620044 | ||
Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts. | Q33352584 | ||
Apoptotic death of cancer stem cells for cancer therapy | Q33755766 | ||
Radiation-induced bystander effects in cultured human stem cells | Q33769819 | ||
Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration | Q34001599 | ||
Defying death after DNA damage. | Q34068957 | ||
Survival responses of human embryonic stem cells to DNA damage | Q34078474 | ||
DNA-damage response in tissue-specific and cancer stem cells | Q37826528 | ||
Stem cell challenges in the treatment of neurodegenerative disease. | Q37954422 | ||
DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis | Q37977244 | ||
The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome | Q37992385 | ||
Genetic and epigenetic stability of human pluripotent stem cells. | Q38042359 | ||
The role of DNA repair in the pluripotency and differentiation of human stem cells. | Q38046388 | ||
Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress | Q39354618 | ||
Activation of DNA damage response pathways in human mesenchymal stem cells exposed to cisplatin or γ-irradiation | Q39451049 | ||
Global phosphoproteome profiling reveals unanticipated networks responsive to cisplatin treatment of embryonic stem cells | Q39665656 | ||
Explanation for excessive DNA single-strand breaks and endogenous repair foci in pluripotent mouse embryonic stem cells | Q39893311 | ||
Quantitative analysis reveals asynchronous and more than DSB-associated histone H2AX phosphorylation after exposure to ionizing radiation. | Q40313015 | ||
Comparative genomic hybridization and karyotyping of human embryonic stem cells reveals the occurrence of an isodicentric X chromosome after long-term cultivation | Q40573420 | ||
The roles of apoptotic pathways in the low recovery rate after cryopreservation of dissociated human embryonic stem cells | Q41156747 | ||
Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery | Q41956611 | ||
Induced pluripotent stem cell technology and stem cell therapy for diabetes | Q42089748 | ||
Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells | Q45047169 | ||
More efficient repair of DNA double-strand breaks in skeletal muscle stem cells compared to their committed progeny | Q50631959 | ||
Differentiation-related response to DNA breaks in human mesenchymal stem cells | Q64386387 | ||
Regulation of apoptosis and differentiation by p53 in human embryonic stem cells | Q79441696 | ||
DNA damage response in adult stem cells: pathways and consequences | Q83389981 | ||
Recurrent copy number variations in human induced pluripotent stem cells | Q84306754 | ||
The role of engineering approaches in analysing cancer invasion and metastasis | Q87110626 | ||
Fixing the breaks in intestinal stem cells after radiation: a matter of DNA damage and death or DNA repair and regeneration | Q87352768 | ||
DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis | Q34132208 | ||
Different roles for nonhomologous end joining and homologous recombination following replication arrest in mammalian cells | Q34284545 | ||
Genetic and epigenetic instability in human pluripotent stem cells. | Q34316491 | ||
Caspase functions in cell death and disease | Q34336335 | ||
Activin A maintains pluripotency markers and proliferative potential of human induced pluripotent stem cells | Q34414522 | ||
Caspases: cellular demolition experts | Q34439510 | ||
Effects of ionizing radiation on self-renewal and pluripotency of human embryonic stem cells. | Q34458727 | ||
Directed differentiation of induced pluripotent stem cells into chondrogenic lineages for articular cartilage treatment | Q34461122 | ||
Human DNA repair genes, 2005. | Q34557999 | ||
Mismatch and base excision repair proficiency in murine embryonic stem cells | Q34709046 | ||
Homologous recombination conserves DNA sequence integrity throughout the cell cycle in embryonic stem cells | Q35084078 | ||
A means to a DNA end: the many roles of Ku. | Q35762470 | ||
Cancer and radiation therapy: current advances and future directions | Q35816527 | ||
Programmed cell death in animal development and disease | Q35878720 | ||
Ionizing radiation induces ataxia telangiectasia mutated-dependent checkpoint signaling and G(2) but not G(1) cell cycle arrest in pluripotent human embryonic stem cells | Q35924505 | ||
DNA repair defects in stem cell function and aging | Q36014742 | ||
Homologous recombination and its regulation | Q36106937 | ||
The role of apoptosis-induced proliferation for regeneration and cancer | Q36119477 | ||
Human embryonic stem cell responses to ionizing radiation exposures: current state of knowledge and future challenges | Q36200201 | ||
Responses of human embryonic stem cells and their differentiated progeny to ionizing radiation | Q36401179 | ||
Human embryonic stem cells have enhanced repair of multiple forms of DNA damage | Q36953410 | ||
The role of DNA damage repair in aging of adult stem cells | Q37045395 | ||
Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology | Q37048178 | ||
Concise review: mesenchymal stem cells for diabetes | Q37056264 | ||
FLIP as an anti-cancer therapeutic target | Q37096732 | ||
DNA repair in murine embryonic stem cells and differentiated cells | Q37122448 | ||
DNA repair in mammalian cells: Base excision repair: the long and short of it. | Q37372532 | ||
Human induced pluripotent cells resemble embryonic stem cells demonstrating enhanced levels of DNA repair and efficacy of nonhomologous end-joining | Q37414043 | ||
Effects of low doses of ionizing radiation exposures on stress-responsive gene expression in human embryonic stem cells | Q37535491 | ||
Genomic instability in pluripotent stem cells: implications for clinical applications | Q37596254 | ||
p53 and stem cells: new developments and new concerns | Q37671364 | ||
Induced pluripotent stem cells for retinal degenerative diseases: a new perspective on the challenges | Q37678795 | ||
Response of normal stem cells to ionizing radiation: a balance between homeostasis and genomic stability | Q37684362 | ||
DNA damage response. | Q37803476 | ||
P433 | issue | 3 | |
P921 | main subject | pluripotency | Q1894941 |
P304 | page(s) | 695-702 | |
P577 | publication date | 2016-01-13 | |
P1433 | published in | Experimental and Therapeutic Medicine | Q23979083 |
P1476 | title | Genetic stability of pluripotent stem cells during anti-cancer therapies | |
P478 | volume | 11 |
Q57799405 | Chondrocytes differentiated from human induced pluripotent stem cells: Response to ionizing radiation |
Q37720218 | Comparison of the early response of human embryonic stem cells and human induced pluripotent stem cells to ionizing radiation. |
Q91588021 | Evaluation of Graphene Oxide Induced Cellular Toxicity and Transcriptome Analysis in Human Embryonic Kidney Cells |
Q33670843 | Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part A |
Q33674433 | Gene expression profile in human induced pluripotent stem cells: Chondrogenic differentiation in vitro, part B. |
Q28069565 | The importance of stem cell engineering in head and neck oncology |
Search more.